[Limitations of current treatment of asthma: possibilities for new treatment forms].
Wilkens
H
H
Innere Medizin V, Medizinische Klinik und Poliklinik, Universität des Saarlandes, Homburg/Saar.
Sybrecht
G W
GW
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000403:Airway Resistance / Q000187:drug effects; D018927:Anti-Asthmatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000209:etiology; D001993:Bronchodilator Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D013256:Steroids; D016896:Treatment Outcome
D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D001993:Bronchodilator Agents; D013256:Steroids
Limitationen der gegenwärtigen Behandlung von Asthma: Möglichkeiten für neue Behandlungsformen.